Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-9179 in diabetic gastroparesis
NCT02289846Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of recanaclotide in diabetic gastroparesis, sponsored by Ironwood Pharmaceuticals. Started Oct 2014; status: completed.
02
Drugs
recanaclotide
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT02289846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289846.